Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Kedudukan dalam Saham #33959
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Harga Saham
$1.83
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$6.53M
Perubahan (1 hari)
-1.61%
Perubahan (1 tahun)
-85.57%
Negara
US
Perdagangan Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategori

Sejarah hasil dividen untuk Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Hasil dividen (TTM) bagi Cadrenal Therapeutics, Inc. Common Stock (simbol saham: CVKD) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Cadrenal Therapeutics, Inc. Common Stock (CVKD) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing